首页> 外文OA文献 >The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine

【2h】

The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine

机译：CD80，CD86和ICAM-1对佐剂配方对增强抗体对疟原虫血液疫苗疫苗的反应的能力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
George Hui; Caryn Hashimoto;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine [J] . Hui G, Hashimoto C Vaccine . 2007,第51期

机译：CD80，CD86和ICAM-1对佐剂制剂增强对恶性疟原虫血液阶段疫苗的抗体应答的能力的要求
2. Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody reponses to a Plasmodium falciparum blood-stage vaccine [J] . Hui G, Hashimoto C Vaccine . 2007,第36期

机译：白介素-6对佐剂制剂增强对恶性疟原虫血液阶段疫苗的抗体应答的能力有不同的影响
3. Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. [J] . Douglas AD, de Cassan SC, Dicks MD, Vaccine . 2010,第44期

机译：定制亚单位疫苗的免疫原性：通过结合使用腺病毒，痘病毒和针对恶性疟原虫MSP1的蛋白质佐剂疫苗，最大限度地提高抗体和T细胞反应。
4. Ability of adjuvants to enhance the systemic antibody responses against H1N1 and H3N2 swine influenza viruses [C] . Boh Chang Lin, R. Gene White, Karen K. Brown, Annual Meeting of the American Association of Swine Veterinarians . 2006

机译：佐剂能够增强对H1N1和H3N2猪流感病毒的全身抗体反应的能力
5. Analysis of vaccine- and infection-induced immune responses contributing to suppression of blood-stage malaria in the Plasmodium yoelii rodent model. [D] . Petritus, Patricia M. 2009

机译：在约氏疟原虫啮齿动物模型中分析疫苗和感染诱导的免疫反应，有助于抑制血液阶段的疟疾。
6. The Requirement of CD80 CD86 and ICAM-1 on the Ability of Adjuvant Formulations to Potentiate Antibody Reponses to a Plasmodium falciparum Blood-Stage Vaccine [O] . George Hui, Caryn Hashimoto -1

机译：CD80CD86和ICAM-1对佐剂制剂增强对恶性疟原虫血液阶段疫苗的抗体应答能力的要求
7. Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1. [O] . Douglas, AD, de Cassan, SC, Dicks, MD, 2010

机译：定制亚基疫苗的免疫原性：通过组合使用针对恶性疟原虫MSP1的腺病毒，痘病毒和蛋白佐剂疫苗来最大化抗体和T细胞反应。
8. Vaxfectin (registered trademark) Enhances Both Antibody and In Vitro T Cell Responses to Each Component of a 5-gene Plasmodium falciparum Plasmid DNA Vaccine Mixture Administered at Low Doses [R] . Sedegah, M., Rogers, W. O., Belmonte, M., 2010

机译：Vaxfectin（注册商标）增强抗体和体外T细胞对5基因恶性疟原虫质粒DNa疫苗混合物各组分的低剂量反应

The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine

著录项

相似文献

相关主题

期刊订阅